Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System
This post-marketing study evaluated on-label performance of GE's Vscan handheld ultrasound imaging system.
-
FDA approval · 2016-03-04FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2016-03-04Clinical Trial Update: Corelab Remotely Echocardiographic Imaging Acquisition in Cardiac Resynchronization Therapy Candidates
Clinical trial update on the use of corelab remotely acquired echocardiographic imaging in candidates for cardiac resynchronization therapy.
-
CLINICAL_TRIALS research · 2016-03-03Clinical Trial Update: The Role of Vitamin D in the Pathophysiology of Chronic Failure [Phase 4]
Phase 4 clinical trial evaluating the role of vitamin D in the pathophysiology of chronic heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Oral Iron Therapy in Chronic Heart Failure Patients [Phase 3]
This clinical trial update concerns a Phase 3 study evaluating oral iron therapy in patients with heart failure.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Effects of a Rehabilitation Program on Immune Activation and Mood in Heart Failure Patients
This completed clinical trial evaluated whether a rehabilitation program influences immune activation and mood in patients with heart failur…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: ProMRI PROVEN Master Study
This completed clinical trial update from Biotronik reports on the ProMRI PROVEN Master Study, which assessed the safety of MR-conditional c…
-
CLINICAL_TRIALS research · 2016-03-02Clinical Trial Update: Hormone KLOTHO Level in Heart Failure Patients That Participate in Rehabilitation Programme
This clinical trial investigates the hormone KLOTHO levels in heart failure patients undergoing a rehabilitation program.
-
CLINICAL_TRIALS research · 2016-03-01Clinical Trial Update: Standard Care Versus Triventricular Pacing in Heart Failure [Phase 3]
A Phase 3 clinical trial evaluating standard care versus triventricular pacing in patients with heart failure. The current status is UNKNOWN…
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters [NA]
This clinical trial update reports on the effects of glucagon-like peptide-1 on haemodynamic parameters in heart failure; the current status…
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Community Surveillance of Congestive Heart Failure
A community-based surveillance study on congestive heart failure has completed, according to NHLBI.
-
FDA approval · 2016-02-28FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
The FDA has approved a supplemental application for RAMIPRIL, allowing Chartwell RX, LLC to market a RAMIPRIL generic product.
-
CLINICAL_TRIALS research · 2016-02-26Clinical Trial Update: Iatrogenic Chronotropic Incompetence and Exercise Tolerance in Heart Failure [NA]
A clinical trial update from The Leeds Teaching Hospitals NHS Trust focusing on iatrogenic chronotropic incompetence and exercise tolerance …
-
CLINICAL_TRIALS other · 2016-02-26Clinical Trial Update: TENS in Optimizer(R) Patients [Phase 4]
Phase 4 clinical trial update indicating completion of a study evaluating transcutaneous electrical nerve stimulation (TENS) in heart failur…
-
FDA approval · 2016-02-25FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for enalapril maleate from Taro Pharmaceuticals U.S.A., Inc., confirming approval of a generic e…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Preoperative Levosimendan in CABG Patients With Poor LV Function [Phase 3]
Phase 3 trial evaluating preoperative levosimendan in patients undergoing coronary artery bypass grafting with poor left ventricular functio…
-
FDA approval · 2016-02-24FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
This clinical trial update summarizes the responses to Cardiac Resynchronization Therapy in patients who had prior right ventricular pacing,…
-
FDA approval · 2016-02-23FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for CAPTOPRIL from Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients [Phase 3]
This document reports a Phase 3 clinical trial exploring the effects of withdrawing furosemide in stable chronic heart failure outpatients. …
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Body Composition Measurements in Chronic Heart Failure [Phase 4]
Phase 4 clinical trial update focusing on body composition measurements in chronic heart failure. The sponsor is the Hungarian Institute of …
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Supporting Care and Independence at Home [NA]
A completed clinical trial evaluating at-home care strategies intended to support independence in heart failure patients.
-
CLINICAL_TRIALS research · 2016-02-19Clinical Trial Update: MPP Narrow QRS:Pilot Study on Multipoint Pacing in Patients With QRS Beetwen 100 and 130 Msec [NA]
This document provides a pilot clinical trial update on multipoint pacing for heart failure patients with QRS duration between 100 and 130 m…
-
FDA approval · 2016-02-18FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for carvedilol submitted by Teva Pharmaceuticals USA, Inc., authorizing a generic carvedilol product…
-
FDA label_change · 2016-02-18FDA Approved: LISINOPRIL — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for lisinopril submitted by Exelan Pharmaceuticals Inc., typically resulting in labeling updates…